LRRK2 and Parkinson disease: None of the LRRK2 variants examined in this study passed Bonferroni multiple test correction after excluding the carriers of p.G2019S and rs76904798, including the previously PD‐linked variants p.N551K (OR_condi: 0.93, 95% CI: 0.88–0.99, P = 0.01506), p.R1398H (OR_condi: 0.93, 95% CI: 0.87–0.98, P = 0.01029), p.M1646T (OR_condi: 1.16, 95% CI: 1.04–1.3, P = 0.00659), and p.N2081D (OR_condi: 1.2, 95% CI: 0.91–1.61, P = 0.2054) (Table 2; Figs. S1–S4).